shí yàn shì实验室xiǎo shǔ小鼠shí dài时代de的rì luò日落:lèi qì guān类器官gǎi biàn改变ái zhèng癌症yán jiū研究
By 2026, there may be a significant change in biomedical research: scientists will gradually reduce animal experiments, and cancer research will begin to use a new method—organoids.
Organoids are three-dimensional 'mini tumors' grown from human stem cells or a patient's tumor tissue.
In the past, scientists often used flat cell cultures and mice for experiments, but these methods differ from the real human situation, so some drugs effective in the lab did not work well in patients.
Organoids retain many characteristics of a patient's tumor, allowing scientists to test drugs on these 'mini tumors' first to see which drugs are more likely to be effective and which may not work.
This way, doctors may be able to choose more suitable treatments for different patients in the future.
Currently, organoids are already used in research on colorectal cancer, breast cancer, lung cancer, prostate cancer, and ovarian cancer.
They can also reduce some animal experiments.
However, organoids are not perfect; for example, they usually lack blood vessels and immune cells.
Nevertheless, this technology is developing rapidly and may play a greater role in cancer treatment in the future.